BROOKE LEWIS: Open Payments
NPI 1952497646 · BOULDER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,594 in 55 payments from 18 companies in 2025. Trend: 2023 $2,743 · 2024 $2,235 · 2025 $1,594
Food & beverage: $1,395Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $264 |
| ABBVIE INC. | 8 | $232 |
| Galderma Laboratories, L.P. | 9 | $209 |
| GENZYME CORPORATION | 6 | $159 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $125 |
| Lilly USA, LLC | 4 | $112 |
| Regeneron Healthcare Solutions, Inc. | 3 | $82 |
| Journey Medical Corporation | 4 | $71 |
| Organon LLC | 4 | $62 |
| LEO Pharma Inc. | 2 | $53 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, SKYRIZI, Cabtreo, EBGLYSS, RINVOQ, VTAMA.
Industry payments across CO — which companies pay providers there.
